A Demographic Look at Cancer Treatment Behaviors during the COVID-19 Pandemic
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: While numerous studies have explored the relationship between COVID-19 and cancer, few have specifically examined the significant impact of the pandemic on cancer patients, particularly concerning their treatments and appointments. Objectives: This study aims to investigate cancer treatment behaviors during the COVID-19 pandemic. Methods: This retrospective quantitative study utilized data from the Centers for Disease Control and Prevention's National Health Interview Survey of 2020. The inclusion criteria were as follows: studies conducted within the United States; patients diagnosed with COVID-19 since the pandemic began; patients diagnosed with cancer within the United States; patients undergoing cancer treatment or in remission since the start of the pandemic; patients who experienced a change, delay, or cancellation of treatment due to the COVID-19 pandemic; patients who experienced a change or delay in cancer care due to the COVID-19 pandemic; patients with a weakened immune system due to prescriptions; and patients who took prescription medication within the past 12 months. The variables were analyzed against population characteristics, including age, race, gender, cancer type, and COVID-19 status. Python Jupyter Notebook (packaged by Anaconda Navigator in R Studio, version 6.4.8), Microsoft Excel for data cleaning and assessment, and SPSS were used for statistical analyses. Results: Chi-Square Analysis (p
Fields of Study & Subjects
COVID-19 and healthcare impacts
Global Cancer Incidence and Screening
Cancer survivorship and care
Publication details
- Journal / source
- medRxiv
- Publication date
- 26 March 2026
- Language
- EN
- Document type
- Preprint